申请人:G.D. SEARLE & CO.
公开号:EP1221441A2
公开(公告)日:2002-07-10
The present invention provides compounds of the formula Ar1-Q-Ar2-Y-R-Z and pharmaceutically acceptable salts thereof wherein Ar1 and Ar2 are optionally substituted aryl moieties, Z is an optionally substituted nitrogen-containing moiety which may be an acyclic, cyclic or bicyclic amine or an optionally substituted monocyclic or bicyclic nitrogen-containing heteroaromatic moiety; Q is a linking group capable of linking two aryl groups; R is an alkylene moiety; Y is a linking moiety capable of linking an aryl group to an alkylene moiety and wherein Z is bonded to R through a nitrogen atom. The compounds and pharmaceutical compositions of the present invention are useful in the treatment of inflammatory diseases which are mediated by LTB4 production, such as proriasis, ulcerative colitis, IBD and asthma.
本发明提供了具有公式Ar1-Q-Ar2-Y-R-Z的化合物及其药用可接受的盐,其中Ar1和Ar2是可选地取代的芳基部分,Z是可选地取代的含氮部分,可以是环状、环状或双环状的胺,或可选地取代的单环或双环的含氮杂芳基部分;Q是能够连接两个芳基团的连接基团;R是烷基亚基;Y是能够连接芳基团和烷基亚基的连接基团,并且其中Z通过氮原子与R键合。本发明的化合物和药物组合物在治疗由LTB4产生介导的炎症性疾病中是有用的,例如银屑病、溃疡性结肠炎、炎症性肠病和哮喘。